[Federal Register Volume 88, Number 132 (Wednesday, July 12, 2023)]
[Notices]
[Pages 44343-44344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-14703]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Reorganization of the National Center on Birth Defects and 
Developmental Disabilities

AGENCY: Centers for Disease Control and Prevention (CDC), the 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: CDC has modified its structure. This notice announces the 
reorganization of the National Center on Birth Defects and 
Developmental Disabilities (NCBDDD). NCBDDD realigned the Office of 
Genomics and Precision Public Health from the Office of Science to the 
NCBDDD, retitled and made mission and functional statements updates to 
some organizational entities.

DATES: This reorganization was approved by the Director of CDC on June 
28, 2023.

FOR FURTHER INFORMATION CONTACT: Kimberly Thurmond, Office of the Chief 
Operating Officer, Office of the Director, Centers for Disease Control 
and Prevention, 1600 Clifton Road NE, MS TW-2, Atlanta, GA 30329. 
Telephone 770-488-4401; Email: [email protected].

SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and 
Prevention) of the Statement of Organization, Functions, and 
Delegations of Authority of the Department of Health and Human Services 
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296, 
October 20, 1980, as amended most recently at 88 FR 9290-9291, dated 
February 13, 2023) is amended to reflect the reorganization of the 
National Center on Birth Defects and Developmental Disabilities, 
Centers for Disease Control and Prevention. Specifically, the changes 
are as follows:
    I. Under Part C, Section C-B, Organization and Functions, insert 
the following:

 National Center on Birth Defects and Developmental 
Disabilities (CF)
 Office of the Director (CF1)
 Resource Management Office (CF12)
 Division of Birth Defects and Infant Disorders (CFB)
 Office of the Director (CFB1)
 Birth Defects Monitoring and Research Branch (CFBB)
 Infant Outcomes Monitoring, Research and Prevention Branch 
(CFBC)
 Division of Human Development and Disability (CFC)
 Office of the Director (CFC1)
 Child Development and Disability Branch (CFCB)
 Disability and Health Promotion Branch (CFCC)
 Division of Blood Disorders (CFD)
 Office of the Director (CFD1)
 Epidemiology and Surveillance Branch (CFBD)
 Hemostasis Laboratory Branch (CFDC)
 Public Health Genomics Branch (CFDD)

    II. Under Part C, Section C-B, Organization and Functions, retitle 
the following organizational units:

 Division of Blood Disorders (CFD) to the Division of Blood 
Disorders and Public Health Genomics (CFD)
 Epidemiology and Surveillance Branch (CFBD) to the Blood 
Disorders Surveillance and Epidemiology Branch (CFBD)

    III. Under Part C, Section C-B, Organization and Functions, delete 
the mission or functional statements for and replace with the 
following:
    National Center on Birth Defects and Developmental Disabilities 
(CF). The mission of the National Center on Birth Defects and 
Developmental Disabilities (NCBDDD) is to improve the health of 
children and adults by preventing birth defects and developmental 
disabilities, and complications of heredity blood disorders; promoting 
optimal child development, and the health and wellness among children 
and adults living with disabilities and those living with or at risk of 
genetic disorder across the lifespan. NCBDDD strives to prevent disease 
save healthcare costs and reduce health disparities in the United 
States. In carrying out this mission, this organization: (1) conducts 
public health research, epidemiological investigations, genomic 
research, laboratory research, demonstration projects and public health 
programs; (2) plans, develops, establishes, and maintains systems of 
surveillance and monitoring the population for these conditions; (3) 
operates regional centers for the conduct of applied epidemiological 
research on these conditions; (4) provides information and education to 
healthcare providers, public health professionals, and the public on 
these conditions; (5) provides technical assistance, consultation, 
capacity building through technology transfer, grants, cooperative 
agreements, contracts, and other means to state, local, international, 
and nonprofit organizations to prevent and control these conditions; 
(6) provides training in the epidemiology of these conditions for 
healthcare professionals within and outside the United States; (7) 
translates scientific findings into intervention, prevention, and 
health promotion strategies; (8) conducts evaluations of programs to 
determine effectiveness; and (9) coordinates activities with other CDC 
organizations and Federal and non-Federal health agencies, as 
appropriate.
    After item 4 of the Office of the Director (CF1) functional 
statement, insert the following:
    Office of the Director (CF1). (5) coordinates with medical, 
scientific, and other professional organizations interested in birth 
defects prevention, genetics, developmental disabilities prevention, 
and disabilities and health, and prevention of complications of 
hereditary blood disorders.

[[Page 44344]]

    After item 4 of the Division of Birth Defects and Infant Disorders 
(CFB1) functional statement, insert the following:
    Division of Birth Defects and Infant Disorders (CFB1). (5) provides 
assistance to state and local health departments on community exposures 
to teratogenic, mutagenic, embryotoxic, other environmental agents, and 
genetic influences adversely interfering with normal growth and 
development.
    Office of the Director (CFD1). (1) provides leadership and guidance 
on strategic planning and implementation, program priority setting, and 
policy development, to advance the mission of the division, NCBDDD, and 
CDC; (2) develops goals, objectives, and the budget; monitors progress 
and allocation of resources, and reports accomplishments, future 
directions, and resource requirements, (3) facilitates scientific, 
policy and program collaboration among divisions and centers, and 
between CDC and other Federal/non-Federal partners; (4) promotes the 
advancement of science throughout the division, supports program 
evaluation, and ensures that research meets the highest standards in 
the field; (5) provides medical expertise and consultation to planning, 
projects, policies and program activities; (6) advises the NCBDDD 
Office of the Director on matters relating to blood disorders and 
genomics and coordinates division responses to requests for technical 
assistance or information on activities supported by the division; (7) 
develops and produces communications tools and public affairs 
strategies to meet the needs of division programs and mission; and (8) 
represents the division at official professional and scientific 
meetings, both within and outside of CDC.
    IV. Under Part C, Section C-B, Organization and Functions, add the 
following functional statements:
    Public Health Genomics Branch (CFDD). (1) identifies and evaluates 
emerging genomic, family health history, and precision health 
applications with the potential to impact population health by 
preventing disease, saving healthcare costs, and reducing health 
disparities in the United States; (2) integrates advances in human 
genomics, machine learning, data science, and predictive analytics 
responsibly and effectively into public health programs and healthcare; 
(3) provides technical assistance and advice to CDC leadership and 
programs, other Federal agencies, state health departments, and other 
external partners by identifying, evaluating, and implementing 
evidence-based genomics and precision health practices to prevent and 
control the country's leading genetic diseases; (4) supports policy, 
education, and surveillance frameworks to promote effective 
implementation of evidence-based recommendations for genomic tests, 
family health history, and precision health applications, as well as 
those applications that will emerge in the future; and (5) conducts 
genomics and epidemiologic studies and analyses to improve public 
health.
    V. Under Part C, Section C-B, Organization and Functions, the 
following organizational unit is deleted in its entirety:

 Office of Public Health Genomics and Precision Public Health 
(CPPE) within the Office of Science (CPP)

Delegations of Authority

    All delegations and redelegations of authority made to officials 
and employees of affected organizational components will continue in 
them or their successors pending further redelegation, provided they 
are consistent with this reorganization.

(Authority: 44 U.S.C. 3101)

Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-14703 Filed 7-11-23; 8:45 am]
BILLING CODE 4163-18-P